(Q33933598)

30 July 2017

Expressions of cancer-testis antigens in human hepatocellular carcinomas (English)

1 reference

30 July 2017

Chen CH

1

1 reference

30 July 2017

Chen GJ

2

1 reference

30 July 2017

Lee HS

3

1 reference

30 July 2017

Huang GT

4

1 reference

30 July 2017

Yang PM

5

1 reference

30 July 2017

Tsai LJ

6

1 reference

30 July 2017

Chen DS

7

1 reference

30 July 2017

Sheu JC

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

30 July 2017

1 reference

30 July 2017

164

1 reference

30 July 2017

2

1 reference

30 July 2017

189-195

1 reference

Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Treatment of hepatocellular carcinoma: too many options?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Serological identification of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

New paths in human cancer serology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

High frequency of expression of MAGE genes in human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Expression of SSX genes in human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

A novel Krüppel-associated box containing the SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

SSX: a multigene family with several members transcribed in normal testis and human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Expression of testicular genes in haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900379-2

7 January 2021

10.1016/S0304-3835(01)00379-2

Identifiers

DOI

1 reference

30 July 2017

1 reference